Inhibition of human recombinant T-type calcium channels by the endocannabinoid N-arachidonoyl dopamine

BACKGROUND AND PURPOSE: N-arachidonoyl dopamine (NADA) has complex effects on nociception mediated via cannabinoid CB(1) receptors and the transient receptor potential vanilloid receptor 1 (TRPV1). Anandamide, the prototypic CB(1)/TRPV1 agonist, also inhibits T-type voltage-gated calcium channel cur...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ross, Hamish R, Gilmore, Andrew J, Connor, Mark
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2009
Matèries:
Research Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2697747/
https://ncbi.nlm.nih.gov/pubmed/19226289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2008.00072.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars